Dyclonine hydrochloride: Difference between revisions
Gerald Chi (talk | contribs) m Protected "Dyclonine" ([Edit=Allow only autoconfirmed users] (expires 12:04, 25 July 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 12:04, 25 July 2014 (UTC))) |
m Protected "Dyclonine hydrochloride": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(12 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{ | {{DrugProjectFormSinglePage | ||
| | |authorTag={{KS}} | ||
| | |OTC=Yes | ||
| | |aOrAn=a | ||
| | |drugClass=local anesthetic | ||
| | |indicationType=treatment | ||
| | |indication=[[pain]],minor irritation,sore mouth,sore throat | ||
| | |adverseReactions=[[rash]], [[Urticaria]] | ||
| | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
| | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
| | |||
| | * Content | ||
| | |||
| | <!--Adult Indications and Dosage--> | ||
| | |||
| | <!--FDA-Labeled Indications and Dosage (Adult)--> | ||
| | |fdaLIADAdult===Indications== | ||
| | |||
* For the temporary relief of the following occasional mouth and throat symptoms: | |||
:*Pain | |||
:*Minor irritation | |||
:*Sore mouth | |||
:*Sore throat | |||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | |||
|fdaLIADPed===Indications== | |||
* For the temporary relief of the following occasional mouth and throat symptoms: | |||
:*Pain | |||
:*Minor irritation | |||
:*Sore mouth | |||
:*Sore throat | |||
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
|warnings='''Stop use and ask a doctor if''' | |||
* Sore throat is severe, lasts for more than 2 days, occurs with or is followed by [[fever]], [[headache]], [[rash]], [[nausea]], or [[vomiting]] | |||
* Sore mouth symptoms last more than 7 days, or irritation, pain, or redness continues or worsens | |||
'''If pregnant or breast-feeding''', ask a health professional before use. | |||
'''Keep out of reach of children'''. In case of overdose, get medical help or contact a Poison Control Center right away. | |||
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | |||
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | |||
|useInPregnancyFDA=* '''Pregnancy Category''' | |||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |||
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | |||
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | |||
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers. | |||
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients. | |||
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients. | |||
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations. | |||
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations. | |||
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment. | |||
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment. | |||
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males. | |||
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised. | |||
|administration=* Oral | |||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |||
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label. | |||
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label. | |||
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label. | |||
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label. | |||
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label. | |||
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label. | |||
|fdaPatientInfo=* Adults and children 6 years of age and older: allow lozenge to dissolve slowly in mouth. May be repeated every 2 hours as needed or as directed by a dentist or doctor. Do not take more than 10 lozenges per day. | |||
* Children under 6 years of age: ask a dentist or doctor. | |||
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication. | |||
|brandNames=* SUCRETS BLACK CHERRY | |||
|lookAlike=* | |||
|drugShortage= | |||
}} | }} | ||
{{ | {{PillImage}} | ||
{{LabelImage | |||
|fileName=Dyclonine ingredients and appearance.png | |||
}} | |||
{{LabelImage | |||
|fileName=Dyclonine image.jpg | |||
}} | |||
<!--Pill Image--> | |||
<!--Label Display Image--> | |||
<!--Category--> | |||
[[Category:Antiseptics]] | |||
[[Category:Drug]] |
Latest revision as of 20:17, 18 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Dyclonine hydrochloride is a local anesthetic that is FDA approved for the treatment of pain,minor irritation,sore mouth,sore throat. Common adverse reactions include rash, Urticaria.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- For the temporary relief of the following occasional mouth and throat symptoms:
- Pain
- Minor irritation
- Sore mouth
- Sore throat
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Dyclonine hydrochloride in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Dyclonine hydrochloride in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Indications
- For the temporary relief of the following occasional mouth and throat symptoms:
- Pain
- Minor irritation
- Sore mouth
- Sore throat
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Dyclonine hydrochloride in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Dyclonine hydrochloride in pediatric patients.
Contraindications
There is limited information regarding Dyclonine hydrochloride Contraindications in the drug label.
Warnings
Stop use and ask a doctor if
- Sore throat is severe, lasts for more than 2 days, occurs with or is followed by fever, headache, rash, nausea, or vomiting
- Sore mouth symptoms last more than 7 days, or irritation, pain, or redness continues or worsens
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Dyclonine hydrochloride in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Dyclonine hydrochloride in the drug label.
Drug Interactions
There is limited information regarding Dyclonine hydrochloride Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Dyclonine hydrochloride in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Dyclonine hydrochloride during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Dyclonine hydrochloride with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Dyclonine hydrochloride with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Dyclonine hydrochloride with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Dyclonine hydrochloride with respect to specific gender populations.
Race
There is no FDA guidance on the use of Dyclonine hydrochloride with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Dyclonine hydrochloride in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Dyclonine hydrochloride in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Dyclonine hydrochloride in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Dyclonine hydrochloride in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
Monitoring
There is limited information regarding Monitoring of Dyclonine hydrochloride in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Dyclonine hydrochloride in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Dyclonine hydrochloride in the drug label.
Pharmacology
There is limited information regarding Dyclonine hydrochloride Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Dyclonine hydrochloride Mechanism of Action in the drug label.
Structure
There is limited information regarding Dyclonine hydrochloride Structure in the drug label.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Dyclonine hydrochloride in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Dyclonine hydrochloride in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Dyclonine hydrochloride in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Dyclonine hydrochloride in the drug label.
How Supplied
There is limited information regarding Dyclonine hydrochloride How Supplied in the drug label.
Storage
There is limited information regarding Dyclonine hydrochloride Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Dyclonine hydrochloride |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Dyclonine hydrochloride |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
- Adults and children 6 years of age and older: allow lozenge to dissolve slowly in mouth. May be repeated every 2 hours as needed or as directed by a dentist or doctor. Do not take more than 10 lozenges per day.
- Children under 6 years of age: ask a dentist or doctor.
Precautions with Alcohol
- Alcohol-Dyclonine hydrochloride interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- SUCRETS BLACK CHERRY
Look-Alike Drug Names
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
{{#subobject:
|Page Name=Dyclonine hydrochloride |Pill Name= |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Dyclonine hydrochloride |Label Name=Dyclonine ingredients and appearance.png
}}
{{#subobject:
|Label Page=Dyclonine hydrochloride |Label Name=Dyclonine image.jpg
}}